Engineering Music to Sound Better With Cochlear Implants

 

When hearing loss becomes so severe that hearing aids no longer help, a cochlear implant not only amplifies sounds but also lets people hear speech clearly.

Music is a different story.

“I’ve pretty much given up listening to music and being able to enjoy it,” says Prudence Garcia-Renart, a musician who gave up playing the piano a few years ago.

“I’ve had the implant for 15 years now and it has done so much for me. Before I got the implant, I was working but I could not use a phone, I needed somebody to take notes for me at meetings, and I couldn’t have conversations with more than one person. I can now use a phone, I recognize people’s voices, I go to films, but music is awful.”

(more…)

Read More

Blind woman’s joy as she is able to read the time thanks to ‘bionic eye’

A patient who is the first in the UK to receive the world’s most advanced ‘bionic eye’ has been able to read the time for the first time in more than five years.

The moment Rhian Lewis, 49, realised she had correctly told the time is captured on BBC’s ‘Trust Me I’m A Doctor’, to be broadcast on Wednesday 6 January 2016.

Surgeons at the Oxford Eye Hospital at Oxford’s John Radcliffe Hospital implanted a tiny electronic chip at the back of Rhian’s retina in her right eye as part of ongoing NHS-funded research of the technology.

(more…)

Read More

Marijuana: A Key To Understanding the Brain ?

Cannabis, weed, grass, hash… a striking variety of names  used to describe this well-recognized drug illustrates its popularity. It may be smoked with tobacco, or using bongos in different forms, including hashish. Known for its recreational and medical uses, cannabis still seems to be an intriguing source of natural substances, of a remarkable potential in treating popular diseases. What if nature has hidden a clou to medical development between green leaves of herbs, like Cannabis sativa?

(more…)

Read More

Oxford Neurosoc Online

Oxford Neurosoc Online is the new service available to our Members. You can use 30GB of Google Drive space, collaborate with others on Sheets, Docs or Slides, share calendars and group lists, and use Hangouts for calls, chats and streaming.

We will seek to expand this service in the forthcoming months, so please do share your suggestions and indeed any feedback you may have at admin@neurologicalsociety.org

Your login will be your email address at neurologicalsociety.org. If you wish to obtain this address or have any technical problems, please contact us at admin@neurologicalsociety.org

The login button will be displayed on the right-hand side of the website, just under the social networking links.

alg

 

Read More

The Society supports AllTrials Initiative – Sign the petition today!

It’s time all clinical trial results are reported.

Patients, researchers, pharmacists, doctors and regulators everywhere will benefit from publication of clinical trial results. Wherever you are in the world please sign the petition:

Thousands of clinical trials have not reported their results; some have not even been registered.

Information on what was done and what was found in these trials could be lost forever to doctors and researchers, leading to bad treatment decisions, missed opportunities for good medicine, and trials being repeated.

All trials past and present should be registered, and the full methods and the results reported.

We call on governments, regulators and research bodies to implement measures to achieve this.

Sign the petition today and support our common cause. 

(more…)

Read More

Does bilingualism really delay age at onset of dementia?

Can you really make that assumption, based on the evidence? Let’s explore it in detail.

ARGUMENT: Bilingualism delays age at onset of dementia, independent of education and immigration status.

The purpose of the study was to determine the association between bilingualism and age at onset of dementia and its subtypes, taking into account potential confounding factors.

 

(more…)

Read More

LSD: From Aztec Rituals to CIA Mind Control

This is the first article of the series of posts about most known drugs. Each week, we’ll discuss one, giving you information about their mode of action, observable effects, and quoting accounts of people exposed to the drug.

Lysergic Acid Diethylamide (LSD) was first synthesised in 1938. It was used in psychiatric research to simulate experimental psychosis. US Army and CIA were working on using it for military purposes, and to control the mind of the suspects during interrogation. First conquistadors also describe very similar psychoses caused by consuming ancient Aztec potions, which were thought to be used as a method of contacting the supernatural powers.

(more…)

Read More